Effect of Continuous Positive Airway Pressure (CPAP) on Abnormal Gastroesophageal Reflux and Lung Inflammation in Idiopathic Pulmonary Fibrosis (IPF)

  • days left to enroll
  • participants needed
  • sponsor
    University of Arizona
Updated on 13 October 2022
idiopathic pulmonary fibrosis


This study will evaluate the effect of CPAP therapy on esophageal pH and lung inflammation in patients with idiopathic pulmonary fibrosis (IPF) and sleep apnea.


Participants in this study will have an overnight sleep study done while wearing a 24 hour pH monitor in the esophagus. If the participant has sleep apnea, he or she will be randomly assigned to receive either CPAP treatment or no CPAP treatment. After 4-8 weeks, the participant will have another overnight sleep study with 24 hour pH monitoring. Blood will also be collected at both time points and again after 6 months to measure biomarkers that are related to lung inflammation.

Condition Idiopathic Pulmonary Fibrosis, Obstructive Sleep Apnea, Gastro Esophageal Reflux
Treatment Positive Airway Pressure
Clinical Study IdentifierNCT05359965
SponsorUniversity of Arizona
Last Modified on13 October 2022


Yes No Not Sure

Inclusion Criteria

confirmed diagnosis of IPF based on the 2018 IPF guidelines
high likelihood of OSA based on the STOP-BANG measure, with a score of 3 or greater
patients on nintedanib, or in whom nintedanib will be initiated prior to enrollment in the study
able to participated in 24hr pH monitoring
able to comply with CPAP treatment
able to provide written informed consent prior to any study procedures
willing to complete all study measurements and assessments in compliance with the protocol

Exclusion Criteria

interstitial lung disease caused by conditions other than IPF
severe concomitant illness limiting life expectancy (< 1 year)
residual lung volume > or equal to 120% of predicted
obstructive lung disease: FEV1/FVC ratio < 0.70
current drug or alcohol dependence
patients who are unable to tolerate nintedanib
patients who are unable to use CPAP or are unwilling to participate in the 24 hr pH probe placement
patients who were diagnosed with recent IPF exacerbation within 4 weeks of enrollment (may be rescheduled for enrollment once recovered)
patients who have had prior nasal surgery or trauma that would make pH probe placement difficult
patients on anticoagulation (aspirin is not an exclusion)
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note